Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Oct 25;13(1):48–54. doi: 10.1016/j.clml.2012.07.009

Figure 3. Survey Respondents’ Assessment of Effective Tyrosine Kinase Inhibitor Therapy When Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients (Question 25).

Figure 3

Abbreviations: CCyR = complete cytogenetic response; HR = hematologic response; MMR = major molecular response; PCyR = partial cytogenetic response.